Paired Comparisons of Main Recorded Variables at Baseline and 9 Months (Control) (n = 39)
| Variable | Baseline* | 9 Mo* | P |
| Active smoking | 8 (21) | 10 (26) | NS |
| Body mass index (kg·m2)† | 28 ± 5 | 28 ± 5 | NS |
| Systolic BP (mm Hg)† | 141 ± 20 | 143 ± 18 | NS |
| Diastolic BP (mm Hg)† | 87 ± 11 | 87 ± 9 | NS |
| Glycemia (mmol·L−1)† | 4.66 ± 1.04 | 4.38 ± 0.86 | NS |
| Insulinemia (mU·L−1)† | 4.53 ± 2.48 | 3.69 ± 1.83 | NS |
| Main medications | |||
| Statins | 28 (72) | 30 (74) | NS |
| ACEI | 20 (51) | 19 (48) | NS |
| ARA II | 9 (23) | 9 (23) | NS |
| PAI | 32 (82) | 30 (75) | NS |
| Vitamin K antagonists | 7 (18) | 7 (18) | NS |
| CT parameters† | |||
| Maximal diameter | 46.0 ± 3.4 | 47.5 ± 4.2 | <0.001 |
| Volume of AAA (cm3) | 101 ± 21 | 110 ± 26 | <0.001 |
| Thrombus volume (cm3) | 40 ± 25 | 47 ± 31 | <0.001 |
| Lumen volume (cm3) | 62 ± 18 | 64 ± 19 | 0.02 |
| 18F-FDG PET parameters† | |||
| SUVmax of AAA | 2.12 ± 0.53 | 2.17 ± 0.69 | NS |
| TBRmax of AAA | 1.55 ± 0.28 | 1.65 ± 0.43 | NS |
| SUVmax of SRA | 2.32 ± 0.58 | 2.30 ± 0.70 | NS |
| TBRmax of SRA | 1.69 ± 0.31 | 1.74 ± 0.32 | NS |
↵* Values are reported as number (percentage) of patients unless otherwise indicated.
↵† Values are reported as mean ± SD.
NS = not significant; BP = blood pressure; ACEI = angiotensin-converting enzyme inhibitor; ARA II = angiotensin II receptor antagonists; PAI = platelet aggregation inhibitors; TBRmax = maximal tissue-to-background ratio; SRA = suprarenal abdominal aorta.